LifePoint Health (LPNT) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Cantor Fitzgerald Reiterates Neutral on LifePoint Health (LPNT) After Adjusting Estimates
February 21, 2017 7:00 AM ESTCantor Fitzgerald reiterated a Neutral rating and $55.00 price target on LifePoint Health (NASDAQ: LPNT) after adjusting estimates. Cantor raised full year 2017 adjusted EPS estimates to $4.10 from $4.00, vs. the $4.13 consensus and the $4.05-$4.34 guidance. Cantor also raised adjusted EBITDA to $778 million (from $745 million) vs. the $803... More
